Monofunctional platinum complexes showing potent cytotoxicity against human liver carcinoma cell line BEL-7402

Journal of Medicinal Chemistry

Volumn 46, Issue 16, 2003, Pages 3502-3507

  Zhang, Junyong ^a   Wang, Xiaoyong ^a   Tu, Chao ^a   Lin, Jun ^a   Ding, Jian ^b   Lin, Liping ^b   Wang, Zheming ^c   He, Cheng ^c   Yan, Chunhua ^c   You, Xiaozeng ^a   Guo, Zijian ^a  

^a NANJING UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PLATINUM ALANINE N' 8 QUINOLYLAMIDE CHLORIDE; PLATINUM COMPLEX; PLATINUM GLYCINE N' 8 QUINOLYLAMIDE CHLORIDE; PLATINUM N (TERT BUTOXYCARBONYL)METHIONINE N' 8 QUINOLYLAMIDE CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; COMPLEX FORMATION; CRYSTAL STRUCTURE; CRYSTALLIZATION; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; NONHUMAN; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CRYSTALLOGRAPHY, X-RAY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LIVER NEOPLASMS; METHIONINE; ORGANOPLATINUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0041842673     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020593j     Document Type: Article

References (28)

1. Wong, E.; Giandomenico, C. M. Current status of platinum-based antitumor drugs. Chem. Rev. 1999, 99, 2451-2466.
2. Lippert, B., Ed. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug; Wiley-VCH: Weinheim, Germany, 1999.
3. Hambley, T. W. Platinum binding to DNA: structural controls and consequences. J. Chem. Soc., Dalton Trans. 2001, 2711-2718.
4. Cleare, M. J.; Hoeschele, J. D. Antitumor activity of group VIII transition metal complexes. I. Platinum(II) complexes. Bioinorg. Chem. 1973, 2, 187-210.
5. Coluccia, M.; Nassi, A.; Boccarelli, A.; Giordano, D.; Cardellicchio, N.; Locker, D.; Leng, M.; Sivo, M.; Intini, F. P.; Natile, G. In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands. J. Inorg. Biochem. 1999, 77, 31-35.
6. 3)L] (L = planar nitrogen base). Effect of L and cis/trans isomerism on sequence specificity and unwinding properties observed in globally platinated DNA. Inorg. Chem. 1999, 38, 3535-3542.
7. Pratesi, G.; Perego, P.; Polizzi, D.; Righetti, S. C.; Supino, R.; Caserini, C.; Manzotti, C.; Giuliani, F. C.; Pezzoni, G.; Tognella, S.; Spinelli, S.; Farrell, N.; Zunino, F. A novel charged trinuclear platinum complex effective against cisplatin-resistant tumors: hypersensitivity of p53-mutant human tumor xenografts. Br. J. Cancer 1999, 80, 1912-1919.
8. Hollis, L. S.; Sundquist, W. I.; Burstyn, J. N.; Heiger-Bernays, W. J.; Bellon, S. F.; Ahmed, K. J.; Amundsen, A. R.; Stern, E. W.; Lippard, S. J. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents. Cancer Res. 1991, 51, 1866-1875.
9. +. J. Med. Chem. 1989, 32, 128-136.
10. 2(4-methylpyridine)Cl]Cl, does not form N7,N7-D(GpG) cheletes with DNA - an unexpected preference for platinum binding at the 5′G in D(GpG). J. Inorg. Biochem. 1990, 40, 23-35.
11. Bauer, C.; Peleg-Shulman, T.; Gibson, D.; Wang, A. H. J. Monofunctional platinum amine complexes destabilize DNA significantly. Eur. J. Biochem. 1998, 256, 253-260.
12. Okada, T.; El-Mehasseb, I. M., Kodaka, M.; Tomohiro, T.; Okamoto, K.; Okuno, H. Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse Sarcoma 180 cells acquiring high cisplatin resistance. J. Med. Chem. 2001, 44, 4661-4667.
13. Zhang, J. Y.; Liu, Q.; Duan, C. Y.; Shao, Y.; Ding, J.; Miao, Z. H.; You, X. Z.; Guo, Z. J. Structural evidence for the facile chelate-ring opening reactions of novel platinum(II)-pyridine carboxamide complexes. J. Chem. Soc., Dalton Trans. 2002, 591-597.
14. Hegmans, A.; Qu, Y.; Kelland, L. R.; Roberts, J. D.; Farrell, N. Novel approaches to polynuclear platinum pro-drugs. Selective release of cytotoxic platinum-spermidine species through hydrolytic cleavage of carbamates. Inorg. Chem. 2001, 40, 6108-6114.
15. 4+ (BBR3464). Inorg. Chem. 2002, 41, 1101-1109.
16. Coluccia, M.; Nassii, A.; Loseto, F.; Boccarelli, A.; Mariggio, M. A.; Giordano, D.; Intini, F. P.; Caputo, P.; Natile, G. A transplatinum complex showing higher antitumor activity than the cis congeners. J. Med. Chem. 1993, 36, 510-512.
17. 2]. Nucleic Acids Res. 1996, 24, 336-341.
18. Farrell, N. DNA-binding and chemistry of dinuclear platinum comlexes. Comments Inorg. Chem. 1995, 16, 373-389.
19. Natile, G.; Coluccia, M. Current status of trans-platinum compounds in cancer therapy. Coord. Chem. Rev. 2001, 216, 383-410.
20. Farrell, N. Transition Metal Complexes as Drugs and Chemotherapeautic Agents; Kluwer Academic Press: Dordrecht, The Netherlands, 1989; p 51.
21. Peleg-shulman, T.; Katzhendler, J.; Gibson, D. Effects of monofunctional platinum binding on the thermal stability and conformation of a self-complementary 22-mer. J. Inorg. Biochem. 2000, 81, 313-323.
22. Barnham, K. J.; Djuran, M. I.; Murdoch, P. del S.; Sadler, P. J. Intermolecular displacement of S-bound L-methionine on platinum(II) by guanosine 5′-monophosphate: implications for the mechanism of action of anticancer drugs. J. Chem. Soc., Chem. Commun. 1994, 721-722.
23. 7 in the nucleopeptide Met-d(TpG) (5′-O-methioninate-N-ylcarbonylthymidine 2′-deoxyguanosine monophosphate). J. Chem. Soc., Dalton Trans. 1997, 3979-3980.
24. 2]. Indian J. Chem. 1970, 8, 193-194.
25. Sheldrick, G. M. SADABS, Program for empirical absorption correction of area detector data; University of Gottingen: Gottingen, Germany, 1996.
26. Sheldrick, G. M. SHELXTL, Structure Determination Software Programs, version 5.10; Bruker Analytical X-ray Systems Inc.: Madison, WI, 1997.
27. Alley, M. C.; Scudiero, D. A.; Monks, A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589-601.
28. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.